Histocell is a private biopharmaceutical company focused on the development, manufacturing and commercialisation of novel medical devices, dermocosmetics and cell therapy drugs for regenerative medicine.


  • Area of Activity
  • Cellular Therapy
  • Research services and supplies
  • Research network
  • Maintenance cell cultures
  • Bone diseases
  • Drug development
  • Medical Devices
  • Muskuloskeletal disorders
  • Cell culture
  • Cosmetics
  • Research Centers
  • Biomaterials
  • Cellular and molecular biology
  • Biodrugs
  • Company type
  • Health Biotechnology
  • Services and consulting for biotech sector
  • Public and Private Organizations - Non Profit Centers - Medical Research Facilities
  • Industrial Biotechnology - Manufacturers
Headquarter
Parque Tecnológico 801A, 2º
Derio, Vizcaya 48160, ES
P: +34 94 656 79 00
F:+34 94 403 69 99
E:info@histocell.com
Office
Histocell Factory - C/Patakon s/n
Larrabetzu , Bizkaia 48195, ES
P: +34 94 656 79 00
F:+34 94 403 69 99
E:info@histocell.com

Histocell counts on a highly qualified multidisciplinary team, made of professionals from both academic and industry fields, including 10 PhDs.

Histocell has a diverse product portfolio, which allows diversifying the risk, with products in different stages of development, from design to marketing. These products are aimed to different therapeutic areas and have an international distribution.

In another line of business, Histocell offers cell manufacturing services for research and clinical trials.

Our products have a common therapeutic approach focused in the protection and regeneration of tissues damaged by inflammatory and oxidative environments, and are backed up by a strong intellectual protection with more than 45 patents so far.

We develop new medical devices and cell therapy drugs to improve people's quality of life. Thus, our target customer is the society in general.

The users of our products and services are diverse, from pharmaceutical companies and research centers, to healthcare personnel and the patients themselves.

Histocell Regenerative Medicine